MARY MLADENKA-DOWDEN: Open Payments
NPI 1538488028 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 11 payments from 6 companies in 2025. Trend: 2023 $58 · 2024 $49 · 2025 $617
Food & beverage: $517Education: $100
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 5 | $325 |
| Calliditas Therapeutics US Inc. | 2 | $144 |
| Mallinckrodt Hospital Products Inc. | 1 | $100 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Fresenius USA Marketing, Inc. | 1 | $16 |
| Recor Medical Inc | 1 | $14 |
Products named: TARPEYO, Filspari, ACTHAR, LOKELMA, VELPHORO, Paradise Ultrasound Renal Denervation System.
Industry payments across LA — which companies pay providers there.
